March Madness starts this week, and even if you're not a fan of college basketball, don't worry. We've got our own tournament with eight analysts facing off against each other. Which stock is a better buy, a biotech software company, or a well-known real estate broker? This segment was recorded during the morning show on the Motley Fool's live video stream.
Regulators seized another bank over the weekend, as the federal government came up with a plan to use money from a fund paid into by U.S. banks to make SVB's depositors whole again.
(0:21) Jason Moser discusses: - Signature Bank failing and shares of First Republic Bank falling 60%. - Why "bailout" is probably not the right word to describe what's happening - How big banks like JPMorgan Chase and Bank of America are gaining strength simply by going about their business
(11:20) We're celebrating our own version of "March Madness" by having analysts face off, bracket-style, as they go head-to-head over which stock is a better buy. Jim Gillies and Jim Mueller kick off the week with a biotech software company and a well-known real estate broker.
Companies discussed: SIVB, SBNY, FRC, SCHW, BAC, JPM, SDGR, RMAX
Host: Chris Hill Guests: Jason Moser, Jim Gillies, Jim Mueller Producer: Ricky Mulvey Engineers: Dan Boyd, Kyle Carruthers
Learn more about your ad choices. Visit megaphone.fm/adchoices